Dr. Ron Do, Assistant Professor, Charles Bronfman Institute for Personalized Medicine, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai


Dr. Ron Do, Ph.D., is an Assistant Professor in the Department of Genetics and Genomic Sciences.  He is appointed as a member of the Charles Bronfman Institute for Personalized Medicine, the Center for Statistical Genetics, the Icahn Institute for Genomics and Multiscale Biology, and the Zena and Michael A. Weiner Cardiovascular Institute.

Prior to joining Mount Sinai, Dr. Do was a Postdoctoral Fellow (2010 to 2013) and Instructor in Medicine (2013 to 2015) at the Center for Human Genetic Research at Massachusetts General Hospital and Harvard Medical School, and a research affiliate at the Broad Institute of MIT and Harvard. 

Dr. Do’s research focuses on the genetic and biological bases of complex traits and diseases with a particular emphasis on coronary artery disease (CAD) and related cardio-metabolic risk factors. Specifically, Dr. Do’s current research activities include: 1) inferring causal relationships between complex traits and diseases; 2) leveraging population genetic approaches to understand the genetic architecture of complex disease; 3) integrating genetic and functional data to understand the phenotypic links between complex traits and diseases; and recently, 4) conducting genetic studies to inform genomic medicine using electronic medical records linked to large-scale biobanks.

Dr. Philip B. Storm, Chief of the Division of Neurosurgery at the Children's Hospital of Pennsylvania


Phillip B. “Jay” Storm, M.D. is the Leslie N. Sutton Endowed Chair of the Division of Neurosurgery at the Children’s Hospital of Philadelphia (CHOP) and the Director of the Center for Data Driven Discovery in Biomedicine (D3b). Dr. Storm is a Summa Cum Laude graduate of Wake Forest University and a member of Phi Beta Kappa. He then earned his medical degree from the Johns Hopkins University School of Medicine and is a member of Alpha Omega Alpha (AOA). Dr. Storm completed his residency in neurological surgery and his fellowship in neuro-oncology research at the Johns Hopkins Hospital. He did a fellowship in pediatric neurosurgery at CHOP in 2003 and joined the faculty at CHOP and the University of Pennsylvania in 2004.

Dr. Storm is internationally recognized for his research and surgical treatment of brain and spine tumors and is a leader in endoscopic skull base surgery and complex reconstructive spine surgery. He co-directs the Resnick/Storm Translational Research Laboratory, now part of their new center, D3b. He leads an international tumor biobanking effort called the Children’s Brain Tumor Tissue Consortium (CBTTC) where the 17 member institutions from around the world send brain tumors to CHOP. In 2016 Drs. Storm and Resnick launched CAVATICA, as part of the White House precision medicine initiative. CAVATICA is a cloud-based biomedical data analysis platform that allows researchers to collaboratively access, analyze and share data about diseases impacting children. In 2017 they were awarded NIH sponsored Gabriella Miller Kid’s First Data Resource Center (DRC) grant. The Kid’s First DRC contains pediatric cancer and congenital birth defects data with the hope of empowering scientists to rapidly make discovery and identify novel therapeutic targets.


Dr. Abigail Berman, Associate Director of the Penn Center for Precision Medicine


Dr. Abigail T. Berman is an Assistant Professor in the Department of Radiation Oncology. She did her undergraduate work at Harvard University in chemistry and medical school and residency at the University of Pennsylvania Perelman School of Medicine, where she also received her Master of Science in Clinical Epidemiology with a focus on clinical trials. She specializes in the treatment of patients with lung cancer and other thoracic malignancies with photon and proton radiation therapy. Dr. Berman leads research programs in translational thoracic radiation oncology, including a focus on the microbiome, and clinical trials incorporating immunotherapy with multi-modality therapy including with reirradiation. Dr. Berman has received research funding from the National Institutes of Health and the Radiologic Society of North America. She is the Associate Director, Clinical, of the Penn Center for Precision Medicine and Director of the medical student radiation oncology clerkship. She is a member of the ITMIG Thymic Carcinoma Workgroup, Penn Thoracic Cancer Service Line Committee, and on the Editorial Board of Frontiers in Oncology.

Dr. Samant Virk, Co-Founder and CEO of MediSprout

Samant Virk_bio - Jacqualine Rubbo.png

Dr. Samant Virk is Founder & CEO of MediSprout, a company focused on connecting doctors with their patients through innovative technology solutions. Samant’s vision is to address the shortcomings of healthcare by enhancing one of the cornerstones of medical practice, the provider-patient interaction.

Having practiced clinical medicine for almost 15 years, with a specialization in Neurology and Interventional Spine, Samant came to the realization that the healthcare system is broken with more physician time being spent filling out insurance paperwork, playing phone tag and chasing follow-ups - and less time treating people, helping families and serving communities. 

Samant founded MediSprout, which aims to solve this with its virtual video product, V2MD, a secure, reliable way for a multitude of practitioners to better connect with their existing patients to build relationships and provide ongoing care.

Dr. Krisda Chaiyachati (MD, MPH, MSHP), Medical Director for Penn Medicine's FirstCall Virtual Care

Chaiyachati_2018 - Krisda Chaiyachati.jpg

Krisda Chaiyachati is the Medical Director for Penn Medicine’s FirstCall Virtual Urgent Care within the Penn Center for Connected Care. Since 2015, when FirstCall was a pilot in collaboration with Penn Medicine’s Center for Health Care innovation, Krisda has been leading the vision and growth of the program to its current state – a 24/7 on-demand virtual care service staffed by full-time nurse practitioners. FirstCall manages a range of low-acuity urgent care needs (e.g., cold symptoms, the flu, rashes, and urinary tract infections) using video and audio-based telecommunication. In addition, the program helps coordinate follow-up care within Penn Medicine when clinically indicated. FirstCall is currently offered exclusively to Penn Medicine employees with plans to expand to other markets over the coming year.

In addition to his FirstCall role, he is an Assistant Professor of Medicine at the University of Pennsylvania and an Innovation Manager for the Accelerator Lab within the Center for Health Care Innovation. His operations work and research revolves around improving access to health care, particularly for low-income or vulnerable populations. For example, he previously studied transportation-based initiatives using Lyft to improve health care access for Medicaid patients. He is currently studying ways telemedicine can be incorporated into how Penn Medicine delivers care and evaluating the costs and quality of telemedicine based care nationally. He has published widely on effective strategies for addressing the social determinants of health, racial disparities in care, and improving access in the New England Journal of Medicine, JAMA Internal Medicine, The Conversation, and The Health Affairs Blog and has been quoted in The Washington Post and CNBC.

 In addition to Krisda’s medical degree from the University of Michigan, he received his Master of Public Health from the Harvard School of Public Health as a Zuckerman Fellow at the Center for Public Leadership and Master of Science in Health Policy Research from the University of Pennsylvania. He completed his internal medicine training with Yale's Primary Care Program and continued on as a Chief Resident. Clinically, he is an internist at a primary care clinic specifically for Penn Medicine employees.

Geoff Pardo, Partner at Gilde Healthcare


Geoff Pardo joined Gilde Healthcare in 2011 as a Partner.  He opened Gilde’s Cambridge, MA office and focuses on Gilde's investments in North America. He led the investments in Inari Medical, Axonics, CVRx, InovaLabs (acquired by ResMed), BionX (acquired by Ottobock) and Vapotherm.  He represents Gilde as a member of the board of directors for each company.

Previously, he was a Partner at Spray Venture Partners where he led investments into Interlace Medical (sold to Hologic), Solace Therapeutics, TearScience (sold to J&J) and Cascade Ophthalmics. He served on the board of Solace, TearScience and Cascade, and was actively involved in Interlace and Conventus Orthopedics.

Geoff also served as President & CEO of Facet Solutions, a spinal implant company focused on treating lumbar spinal stenosis until the company was sold to Globus Medical in 2011. He has also worked at Cardinal Partners as an Associate leading their investing activity in the medical device sector.

Geoff began his career in medical devices as a product manager with Synthes USA.

He has a B.A. with honors in History from Brown University and an M.B.A. from the Wharton School of Business.

Mathew Farkash, Founding Partner at Blueprint Health

MSF - Mathew Farkash.jpg

Mathew is a Founding Partner at Blueprint Health, a healthcare accelerator fund, which was named a top 10 most innovative healthcare company in the world by Fast Company.  He is an investor in over 70 early stage companies, works with Fortune 500 companies on technology strategies, and is a Venture Advisor at a new healthcare VC fund backed by 6 US health systems.  Mathew is an international speaker on topics like entrepreneurship and resiliency and an Executive Board Member at Venture for America, a non-profit that leverages entrepreneurship for job creation in underserved cities. 

Mathew is a graduate of Brown University and NYU Stern.

Elizabeth Celata, Project Leader at Boston Consulting Group

Celata_Elizabeth - Elizabeth Celata.jpg

Elizabeth is a Project Leader with the Boston Consulting Group, based in Philadelphia. She earned her MBA in Health Care Management, with honors, from The Wharton School in 2017, and was a recipient of the Kaiser Family Foundation Merit Award. She holds BS in Economics also from the Wharton School, with concentrations in Business and Public Policy and Health Care Management as well as a minor in History and Legal Studies. At BCG, her work has focused on corporate, marketing and sales strategy in biopharmaceuticals. She has worked on a wide range of efforts including business and customer model transformations, commercial strategy and commercial excellence initiatives across a variety of therapeutic areas. 

Richard Forman, Managing Partner at Health Venture Group


Richard D. Forman is currently the managing partner of Health Venture Group, LLC a private investment company focused on technology and consumer related health care investments.  He is also a co-founder of Vitals.Com, one of the leading healthcare IT companies focused on transparency and cost-savings.  Vitals has been funded with over $85 million including its most recent round led by Goldman Sachs.  He has a history of investing in early stage companies and providing hands on efforts to grow these companies into sustainable entities with long term value for shareholders.

He is also an investor in other health care companies including Centrihealth (sold to UnitedHealthcare for more than $300 million) , Startup Health, Blueprint Health, Maxwell Health and Doctor.com.

Mr. Forman is a board member for Maimonides Medical Center (“MMC”), the leading treatment facility and academic medical center in Brooklyn, NY.  MMC has approximately $1.2 billion in revenue; annually serves over 50,000 patient discharges, over 150,000 emergency room visits; and has over 1,000 staff physicians. 

Previously, Mr. Forman was co-Founder, President and CEO of Register.com, Inc. (NASDAQ-RCOM) through June of 2003.  During his tenure, Mr. Forman led the Company through explosive growth and change including

  • Grew revenue to over $115mm

  • Successfully completed three (3) acquisitions, including one cross-border EU based acquisition

  • Raised over $150mm through a series of private and public (IPO) offerings of preferred and common stock

  • Generated $100mm in cumulative operating cash flows and achieved 12 quarters of positive operating cash flow

  • Received the Ernst & Young Entrepreneur of the Year Award (Winner in 2002 and a Finalist in 2000)

In addition, Mr. Forman was instrumental in deregulating the domain name market.  Mr. Forman assisted the industry and the Department of Commerce in delegating its internet responsibilities to the Internet Corporation for Assigned Names and Numbers (ICANN). 

Also, Mr. Forman was a consultant with Booz & Company, the oldest and one of the leading international management consulting firms.  At the firm, he worked out of the New York, NY and Sydney, Australia offices and consulted on systems, operations and strategy assignments. 

Mr. Forman is a Cum Laude graduate of the University of Pennsylvania's Management and Technology Program where he earned a B.S. in Economics from the Wharton School and a B.S. in Electrical Engineering from the Moore School. He also obtained a Masters Degree from New York University's Real Estate Institute.  Currently, he sits on the Board of Overseers for the School of Engineering at Penn.

Dr. John Chuo, SPROUT Pediatric Telehealth Research Collaborative Chair, Clinical Champion for Digital Health Evaluation, Neonatal Quality Officer


Dr. John Chuo is an Associate Professor of Clinical Pediatrics at the Perelman School of Medicine, of the University of Pennsylvania. Dr. Chuo earned his Masters of Biomedical Informatics at the Joint MIT-Harvard Program in Health Science and Technology and received his training as a Quality Improvement Advisor from the Institute for Healthcare Improvement.  As the Neonatal Quality Officer for the CHOP Newborn Care Network, Clinical Champion for Digital Health Evaluation at CHOP, and a practicing Neonatologists at the CHOP Neonatal/Infant Intensive Care Unit, Dr. Chuo has built successful Quality Programs that utilize Informatics and Quality Improvement frameworks to achieve value driven healthcare.  His research and numerous publications are focused on implementation science, team intelligence, and the implementation of telemedicine as a quality improvement intervention.  As a Cofounder and current chair of SPROUT (Supporting Pediatric Research in Outcomes and Utilization of Telehealth), Dr. Chuo is focused on using Pediatric Telehealth research collaboratives to identify best or potential best practices for using telemedicine in order to meet the triple aim.

John Bermel, Chief Financial Officer of Healthfirst


Mr. Bermel has been the CFO of Healthfirst since February 2016, bringing more than 20 years of health care industry experience to his role. Healthfirst is the largest not-for-profit health plan in New York City and in New York State with over $10.5 billion in revenue and 1.35 million members.  Through several broad roles, John has demonstrated success in financial management, turnaround and change management and as a trusted advisor to executive management. John spent 17 years at Aetna where he began as Controller of the Health Business and then was the CFO for Business Operations, serving as the company’s Senior Business Unit Finance Officer for the large part of his tenure. John was a key member of the management team responsible for the historic turnaround of Aetna.  Prior to joining Aetna, John served as Controller of Insurance Operations at United Healthcare and as Controller of MetraHealth, which United Healthcare purchased. He also spent over 11 years in public accounting serving insurance clients. John holds a Bachelor of Science in Business Administration from Georgetown University and a Masters of Business Administration in Finance from The Wharton School (WEMBA).


Geralyn Trujillo, Director of the Office of Public Policy at Independence Blue Cross

Geralyn Trujillo.jpg

Geralyn Trujillo is the Director of the Office of Public Policy at Independence Blue Cross.  As the Director, she provides leadership, program development and management for all public policy initiatives. Responsible for an integrated and disciplined approach to public policy matters that aligns with the company’s strategic and corporate goals and objectives, she leads a team of five to provide direction on federal and state legislative and regulatory initiatives that impacts IBC and its customers.  Other duties include overseeing the development of policy positions and supporting documentation related to key issues, researching and evaluating emerging issues, and working closely with our in-house subject matter experts to ensure our policy positions accurately reflect and support current and future processes and programs.

Previously, she was an Executive Director, Product Policy for America's Health Insurance Plans (AHIP) in Washington, DC.  In this capacity, she was responsible for advocating on behalf of AHIP's Medigap and Supplemental Insurance member plans.  One of her primary responsibilities was to serve as a representative of AHIP before the NAIC on Medicare Supplement and supplemental insurance issues.  Prior to that role, she was the Regional Director for the MidAtlantic/Mideast Region for AHIP's State Affairs team.  In that role, she worked closely with ten states as the primary lead for legislative and regulatory activity within the region.  She also served as the primary point of contact with the National Conference of State Legislatures (NCSL).  Formerly a Senior Legislative Representative on AARP’s Government Affairs State Health & Family Team, she has nearly fifteen years’ worth of state health policy experience, handling a portfolio that has included pharmacy, state insurance, and long-term care issues.  At AARP, she focused on state health and family issues, with an emphasis on private insurance, ACA implementation, pharmaceuticals, and long-term care.  Prior to AARP, Geralyn was the Director of State Government Affairs for the American Society of Health-System Pharmacists (ASHP).  She also worked for the American Academy of Actuaries, as the Senior Health Policy Analyst for State Issues.

Geralyn earned her masters of public policy from the American University in Washington, D.C. She earned her undergraduate degree in business administration and management from Virginia Commonwealth University.

Jeffrey Bechtel, Senior Vice President for Health Economics and Policy for The Hospital & Healthsystem Association of Pennsylvania

Jeff Bechtel.JPG

Jeffrey W. Bechtel is Senior Vice President for Health Economics and Policy for The Hospital & Healthsystem Association of Pennsylvania (HAP). In this capacity, Mr. Bechtel is responsible for leading HAP’s policy development process and serving as the primary liaison with the Medicaid program on health care delivery and financing.

Prior to his role with HAP, Mr. Bechtel was the owner of Bechtel Healthcare Consulting LLC, where he provided consulting and policy support to all physical health managed care organizations (MCOs) that participate in HealthChoices, Pennsylvania’s mandatory Medicaid Managed Care Program. In this role, Mr. Bechtel worked with MCO senior leadership to develop policy recommendations relating to major Commonwealth initiatives. 

Before entering the private sector, Mr. Bechtel had 14 year career with the Commonwealth’s Department of Public Welfare (now known as the Department of Human Services). Among other roles, Mr. Bechtel served as Director of the Bureau of Managed Care Operations, where he was responsible for administering the HealthChoices Medicaid managed care program in Pennsylvania. He also served as Director of the Bureau of Program Integrity, the office responsible for administering a multi-faceted statewide program to protect the financial integrity of Pennsylvanian’s Medicaid Program. Prior to these management roles, Mr. Bechtel served as an attorney in the Department of Public Welfare’s Office of Legal Counsel and in private practice. 

Mr. Bechtel holds a Bachelor of Arts degree in Economics and Government from the College of William and Mary, and a Juris Doctor, cum laude, from The George Washington University National Law Center.

Sally Poblete, CEO and Founder of Wellthie

Sally Poblete Headshot.jpg

Sally is the chief visionary, growth officer, insurance geek, and cheerleader at Wellthie.  She spends most of her time listening to customers, envisioning new ideas, and building the best team.  She envisions a future world where purchasing insurance is a satisfying and confident experience.

Prior to starting Wellthie, Sally spent close to a decade as an executive at Anthem BlueCross BlueShield where she led product development and launched large enterprise initiatives across the country.  With a builder’s DNA,  Sally spent the first decade of her career wearing business development, marketing, and product hats at successful start-ups like Medscape and another insurance start-up Healthmarkets.

Sally received her MBA from the Wharton School’s Health Care Management program where is an active alumna and mentor.  She received her B.S. in Management magna cum laude from the Stern School of Business of New York University.

She is the proud mother of two strong daughters from whom she derives endless inspiration.

Dr. Aditi Sen, Health Economist and Professor at the Johns Hopkins Bloomberg School of Public Health


Aditi P. Sen is a health economist and assistant professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Her research addresses the potential of innovative payment and delivery models, as well as insurance design, to improve the quality and value of health care. In addition, her research seeks to apply insights from behavioral economics to understand provider and consumer behavior. From 2015-16, she was a Health and Aging Policy Fellow in the Office of the Assistant Secretary for Planning and Evaluation at the U.S. Department of Health and Human Services. She also served for a year on the staff of the White House's Council of Economic Advisers. Dr. Sen received her B.A. from Yale University and her Ph.D. in health economics from the Wharton School of the University of Pennsylvania.